Literature DB >> 7612156

Caffeine reduces low-frequency delta activity in the human sleep EEG.

H P Landolt1, D J Dijk, S E Gaus, A A Borbély.   

Abstract

In view of the hypothesis that adenosine is involved in sleep regulation, the effects of the adenosine antagonist caffeine on sleep and sleep EEG were investigated in eight young males. Compared to the placebo condition, caffeine (100 mg) administered at bedtime prolonged sleep latency and reduced sleep efficiency and stage 4 of non-rapid eye movement sleep (NREMS). Electroencephalographic slow-wave activity (SWA, spectral power density in the 1.75-4.5-Hz band) was reduced, whereas power density in the spindle frequency range was slightly enhanced. The suppression of SWA was limited to the first NREMS episode. Caffeine reduced the power density mainly in the lowest delta band, in contrast to the changes during physiological sleep that encompass both the delta and theta bands. Caffeine levels in saliva, assessed in a separate experiment, decreased from 7.5 mumol/l in the first hour of sleep to 3.5 mumol/l in the seventh hour. In the night following caffeine administration, stage 4 sleep had reverted to the baseline level, but sleep latency was still increased, and stage 2 sleep, as well as SWA in the first NREMS episode, were reduced. The data show that even a low dose of caffeine affects the sleep EEG. However, the effects of caffeine did not completely mimic the spectral changes observed during physiological sleep.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612156     DOI: 10.1016/0893-133X(94)00079-F

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  37 in total

Review 1.  Circadian system, sleep and endocrinology.

Authors:  Christopher J Morris; Daniel Aeschbach; Frank A J L Scheer
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

2.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 3.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

4.  Defending sleepwalkers with science and an illustrative case.

Authors:  Rosalind D Cartwright; Christian Guilleminault
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

Review 5.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Activation of the GABAergic Parafacial Zone Maintains Sleep and Counteracts the Wake-Promoting Action of the Psychostimulants Armodafinil and Caffeine.

Authors:  Christelle Anaclet; Kobi Griffith; Patrick M Fuller
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

7.  Caffeine in the neonatal period induces long-lasting changes in sleep and breathing in adult rats.

Authors:  Gaspard Montandon; Richard L Horner; Richard Kinkead; Aida Bairam
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

Review 8.  Sleep as a fundamental property of neuronal assemblies.

Authors:  James M Krueger; David M Rector; Sandip Roy; Hans P A Van Dongen; Gregory Belenky; Jaak Panksepp
Journal:  Nat Rev Neurosci       Date:  2008-11-05       Impact factor: 34.870

9.  Adenosine and sleep.

Authors:  Theresa E Bjorness; Robert W Greene
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats.

Authors:  Md Noor Alam; Sunil Kumar; Seema Rai; Melvi Methippara; Ronald Szymusiak; Dennis McGinty
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.